PRESENTATION

Q3 FY2021 — Presentation

Q3 FY2021PDF · 14 pages1.6 MB
Fiscal Year 2021, Third Quarter
January 29, 2021
EARNINGS CALL
PRESENTATION

-- 1 of 14 --

2
HORACIO ROZANSKI
President and Chief Executive Officer
LLOYD HOWELL, JR.
Chief Financial Officer and Treasurer
RUBUN DEY
Director of Investor Relations
CALL
PARTICIPANTS

-- 2 of 14 --

3
DISCLAIMER
Forward Looking Safe Harbor Statement
Certain statements contained in this presentation and in related comments by our management include “forward-looking statements” within the meaning of the Private
Securities Litigation Reform Act of 1995. Examples of forward-looking statements include information concerning Booz Allen’s preliminary financial results, financial outlook and
guidance, including forecasted revenue, Diluted EPS, Adjusted Diluted EPS, free cash flow, future quarterly dividends, and future improvements in operating margins, as well as
any other statement that does not directly relate to any historical or current fact. In some cases, you can identify forward-looking statements by terminology such as “may,”
“will,” “could,” “should,” “forecasts,” “expects,” “intends,” “plans,” “anticipates,” “projects,” “outlook,” “believes,” “estimates,” “predicts,” “potential,” “continue,”
“preliminary,” or the negative of these terms or other comparable terminology. Although we believe that the expectations reflected in the forward-looking statements are
reasonable, we can give you no assurance these expectations will prove to have been correct.
These forward-looking statements relate to future events or our future financial performance and involve known and unknown risks, uncertainties and other factors that may
cause our actual results, levels of activity, performance or achievements to differ materially from any future results, levels of activity, performance or achievements expressed or
implied by these forward-looking statements. A number of important factors could cause actual results to differ materially from those contained in or implied by these forward-
looking statements, including those factors discussed in our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the fiscal
year ended March 31, 2020, which can be found at the SEC’s website at 	www.sec.gov. All forward-looking statements attributable to us or persons acting on our behalf are
expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made and, except as required by law, we undertake no
obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.
Note Regarding Non-GAAP Financial Data Information
Booz Allen discloses in the following information Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue,
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net Income, Adjusted Diluted EPS, and Free Cash Flow which are not recognized measurements
under GAAP, and when analyzing Booz Allen’s performance or liquidity as applicable, investors should (i) evaluate each adjustment in our reconciliation of revenue to Revenue,
Excluding Billable Expenses, operating income to Adjusted Operating Income, net income to Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on
Revenue, Excluding Billable Expenses, Adjusted Net Income and Adjusted Diluted Earnings Per Share, and net cash provided by operating activities to Free Cash Flow, and the
explanatory footnotes regarding those adjustments, each as defined under GAAP, (ii) use Revenue, Excluding Billable Expenses, Adjusted Operating Income, Adjusted EBITDA,
Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue Excluding Billable Expenses, Adjusted Net Income, and Adjusted Diluted EPS in addition to, and not
as an alternative to revenue, operating income, net income or diluted EPS as measures of operating results, and (iii) use Free Cash Flow in addition to and not as an alternative to
net cash provided by operating activities as a measure of liquidity, each as defined under GAAP. The Financial Appendix includes a reconciliation of Revenue, Excluding Billable
Expenses, Adjusted Operating Income, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue, Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses, Adjusted Net
Income, Adjusted Diluted EPS, and Free Cash Flow to the most directly comparable financial measure calculated and presented in accordance with GAAP. Booz Allen presents
these supplemental performance measures because it believes that these measures provide investors and securities analysts with important supplemental information with
which to evaluate Booz Allen’s performance, long term earnings potential, or liquidity, as applicable and to enable them to assess Booz Allen’s performance on the same basis as
management. These supplemental performance and liquidity measurements may vary from and may not be comparable to similarly titled measures by other companies in Booz
Allen’s industry. With respect to our expectations under “Full Year FY21 Guidance,” reconciliation of Adjusted Diluted EPS guidance to the closest corresponding GAAP measure
is not available without unreasonable efforts on a forward-looking basis due to our inability to predict our stock price, equity grants and dividend declarations during the course
of fiscal 2021. Projecting future stock price, equity grants and dividends to be declared would be necessary to accurately calculate the difference between Adjusted Diluted EPS
and GAAP EPS as a result of the effects of the two-class method and related possible dilution used in the calculation of EPS. Consequently, any attempt to disclose such
reconciliation would imply a degree of precision that could be confusing or misleading to investors. We expect the variability of the above charges to have an unpredictable, and
potentially significant, impact on our future GAAP financial results. For the same reason, a reconciliation of Adjusted EBITDA Margin on Revenue guidance to the closest
corresponding GAAP measure is not available without unreasonable efforts on a forward-looking basis due to our inability to predict specific quantifications of the amounts that
would be required to reconcile such measures.

-- 3 of 14 --

4
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2021 RESULTS
(1) Comparisons are to prior fiscal year period
THIRD QUARTER 	(1) 	YEAR TO DATE (12/31/20) 	(1)
Revenue 	$1.9 billion 	3.0% Increase 	$5.9 billion 	7.0% Increase
Revenue, Excluding Billable Expenses 	$1.3 billion 	6.2% Increase 	$4.1 billion 	9.1% Increase
Adjusted EBITDA 	$205 million 	7.7% Increase 	$647 million 	11.2% Increase
Adjusted EBITDA Margin on Revenue 	10.8% 	4.7% Increase 	11.0% 	4.0% Increase
Net Income 	$144 million 	28.9% Increase 	$410 million 	19.2% Increase
Adjusted Net Income 	$145 million 	27.7% Increase 	$418 million 	20.9% Increase
Diluted EPS 	$1.03 	30.4% Increase 	$2.93 	21.1% Increase
Adjusted Diluted EPS 	$1.04 	30.0% Increase 	$3.01 	22.9% Increase
Net Cash Provided by Operating Activities 	$233 million 	133.4% Increase 	$799 million 	118.0% Increase

-- 4 of 14 --

5
Q3 FY'21 PERFORMANCE
ALIGNED WITH INVESTMENT THESIS
– 	Organic revenue growth of 3.0% year-over-year; headcount and backlog growth of 1.4% and 6.1%
year-over-year, respectively
– 	FY21 guidance midpoint implies an annualized organic revenue CAGR of ~8.5% over FY18-FY21
INDUSTRY LEADING ORGANIC
REVENUE GROWTH
CONTRACT PERFORMANCE
DRIVES MARGIN EXPANSION
PRUDENT CAPITAL
DEPLOYMENT
– 	Adj. EBITDA Margin on Revenue of 10.8%; Adj. EBITDA of $205.4 million (7.7% growth year-over-year)
– 	Organic growth and strong contract-level execution continue to drive profitability
– 	Updated FY21 guidance of Adj. EBITDA Margin on Revenue in the mid to high 10% range
– 	Deployed $142 million in the third quarter (inclusive of the $72 million minority investment)
– 	Announced a quarterly dividend increase of $0.06 to $0.37 per share
INVESTMENT THESIS
Unique Market Position 	Strong Financial Returns 	Option Value	= 	+
~80% - 90% ADEPS GROWTH BY FY'21
+ ~2% DIVIDEND YIELD
– 	Investments in innovation, talent,
and capabilities position us to help
clients adopt current and new
technologies
– 	First mover advantage enhanced by
our ability to combine mission
knowledge, consulting heritage and
technical depth, creating value for
critical missions and top priorities
– 	Continued investment
in new business lines
and solutions that will
drive future growth
FY18 - FY21
4.8 - 6.0% Mid to High
10% ~$1.4B
FY21 Revenue
Growth
FY21 Adj. EBITDA
Margins
FY18-FY21 Capital
Deployment
(1)
(1) As measured over the three-year Investment Thesis period

-- 5 of 14 --

6
KEY FINANCIAL RESULTS
THIRD QUARTER FISCAL YEAR 2021 RESULTS
(1) Comparisons are to prior fiscal year period
THIRD QUARTER 	(1) 	YEAR TO DATE (12/31/20) 	(1)
Revenue 	$1.9 billion 	3.0% Increase 	$5.9 billion 	7.0% Increase
Revenue, Excluding Billable Expenses 	$1.3 billion 	6.2% Increase 	$4.1 billion 	9.1% Increase
Adjusted EBITDA 	$205 million 	7.7% Increase 	$647 million 	11.2% Increase
Adjusted EBITDA Margin on Revenue 	10.8% 	4.7% Increase 	11.0% 	4.0% Increase
Net Income 	$144 million 	28.9% Increase 	$410 million 	19.2% Increase
Adjusted Net Income 	$145 million 	27.7% Increase 	$418 million 	20.9% Increase
Diluted EPS 	$1.03 	30.4% Increase 	$2.93 	21.1% Increase
Adjusted Diluted EPS 	$1.04 	30.0% Increase 	$3.01 	22.9% Increase
Net Cash Provided by Operating Activities 	$233 million 	133.4% Increase 	$799 million 	118.0% Increase
Page 4 intentionally repeated

-- 6 of 14 --

7
$22.0
HISTORICAL BACKLOG & BOOK-TO-BILL
(1) For more information on the components of backlog, and the differences between
backlog and remaining performance obligations, please see the Company's Form 10-K for
the fiscal year ended 3/31/20
BACKLOG ($ IN BILLIONS) 	(1)
(2) Revenue as adjusted from previously reported to reflect ASC 606 and ASU 2017-07
(3) Revenue as reported, reflecting ASC 606 and ASU 2017-07
(4) Totals round to $20.5 billion, $22.9 billion, $22.0 billion, and $23.0 billion, respectively
BOOK-TO-BILL TRENDS
(3)	(2) 	(3) 	(3) 	(3) 	(3) 	(3) 	(3)
(3)
$20.5
(3)
$22.9
(4)	(4) $23.0 (4)
(3) 	(3)
(3) 	(3) 	(3) 	(3) 	(3) 	(3) 	(3)	(3) 	(3)
(4) 	$22.0
(2)
(3)
(3)

-- 7 of 14 --

8
CAPITAL ALLOCATION
DELIVERING STRONG CAPITAL RETURNS THROUGH EFFICIENT CAPITAL DEPLOYMENT
STRATEGY
– 	Our multi-year capital deployment plan is to follow a disciplined and opportunistic approach, subject to market conditions
– 	Deployed $142 million during the third quarter through dividends, share repurchases and a minority investment
– 	~$370 million remaining in our three-year target to deploy ~$1.4 billion through fiscal year 2021
– 	In January, our Board approved a $400 million increase in our share repurchase authorization (remaining capacity: ~$746.5 million)
– 	The Board authorized a dividend increase to 37 cents per share payable on March 2nd to stockholders of record on February 12th
– 	Our capital allocation priorities remain unchanged: working capital needs, quarterly dividend, required capex, strategic
acquisitions, share repurchases, special dividends, and debt repayment (in order)
HISTORICAL CAPITAL DEPLOYMENT ($ IN MILLIONS)	QUARTERLY CAPITAL DEPLOYMENT ($ IN MILLIONS)
(2)
(1) Includes ~$0.1M of withhold to cover shares
(2) Represents Payments for Business Acquisitions, Net of Cash Acquired
$22.5
(2)
(1)

-- 8 of 14 --

9
FINANCIAL OUTLOOK
FULL YEAR FY21 GUIDANCE
OPERATING PERFORMANCE 	CURRENT 	PRIOR (Q2'21)
Revenue Growth 	4.8 - 6.0% 	7.0 - 9.0%
Adjusted EBITDA Margin on Revenue 	Mid to high 10% 	Low to mid 10%
Adjusted Diluted EPS 	$3.70 - $3.85 	$3.60 - $3.75
Net Cash Provided by Operating Activities 	$625 - $675 million 	$600 - $650 million
ASSUMPTIONS FOR ADEPS GUIDANCE 	CURRENT 	PRIOR (Q2'21)
Tax Rate 	20 - 23% 	20 - 23%
Share Count 	136 - 140 million 	136 - 140 million

-- 9 of 14 --

10
APPENDIX

-- 10 of 14 --

11
NON-GAAP FINANCIAL INFORMATION
• 	"Revenue, Excluding Billable Expenses" represents revenue less billable expenses. We use Revenue, Excluding Billable Expenses
because it provides management useful information about the Company's operating performance by excluding the impact of costs
that are not indicative of the level of productivity of our consulting staff headcount and our overall direct labor, which management
believes provides useful information to our investors about our core operations.
• 	"Adjusted Operating Income" represents operating income before transaction costs, fees, losses, and expenses, including fees
associated with debt prepayments and supplemental employee benefits due to the COVID-19 outbreak. We prepare Adjusted
Operating Income to eliminate the impact of items we do not consider indicative of ongoing operating performance due to their
inherent unusual, extraordinary, or non-recurring nature or because they result from an event of a similar nature.
• 	"Adjusted EBITDA" represents net income before income taxes, net interest and other expense and depreciation and amortization
and before certain other items, including transaction costs, fees, losses, and expenses, including fees associated with debt
prepayments and supplemental employee benefits due to the COVID-19 outbreak. “Adjusted EBITDA Margin on Revenue” is
calculated as Adjusted EBITDA divided by revenue. Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses is calculated as
Adjusted EBITDA divided by Revenue, Excluding Billable Expenses. The Company prepares Adjusted EBITDA, Adjusted EBITDA Margin
on Revenue, and Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses to eliminate the impact of items it does not
consider indicative of ongoing operating performance due to their inherent unusual, extraordinary or non-recurring nature or
because they result from an event of a similar nature.
• 	"Adjusted Net Income" represents net income before: (i) transaction costs, fees, losses, and expenses, including fees associated with
debt prepayments, (ii) supplemental employee benefits due to the COVID-19 outbreak, (iii) research and development tax credit, (iv)
release of income tax reserves, (v) loss on debt extinguishment and (vi) amortization of debt issuance costs, in each case net of the
tax effect where appropriate calculated using an assumed effective tax rate. We prepare Adjusted Net Income to eliminate the
impact of items, net of tax, we do not consider indicative of ongoing operating performance due to their inherent unusual,
extraordinary, or non-recurring nature or because they result from an event of a similar nature.
• 	"Adjusted Diluted EPS" represents diluted EPS calculated using Adjusted Net Income as opposed to net income. Additionally, Adjusted
Diluted EPS does not contemplate any adjustments to net income as required under the two-class method of calculating EPS as
required in accordance with accounting principles generally accepted in the United States, or GAAP.
• 	"Free Cash Flow" represents the net cash generated from operating activities less the impact of purchases of property, equipment,
and software.

-- 11 of 14 --

12
NON-GAAP FINANCIAL INFORMATION
(a) Fiscal 2020 debt refinancing costs
incurred in connection with the refinancing
transactions consummated on November 26,
2019.
(b) Represents the supplemental contribution
to employees' dependent care FSA accounts
in response to the COVID-19 outbreak.
(c) Reflects the combination of Interest
expense and Other (expense) income, net
from the condensed consolidated statement
of operations.
(d) Reflects tax credits, net of reserves for
uncertain tax positions, recognized in fiscal
2021 related to an increase in research and
development credits available for fiscal years
2016 to 2019.
(e) Release of pre-acquisition income tax
reserves assumed by the Company in
connection with the Carlyle acquisition.
(f) Reflects the loss on debt extinguishment
resulting from the redemption of Booz Allen
Hamilton Inc.'s 5.125% senior notes due
2025, including $9.0 million of the premium
paid at redemption, and write-off of the
unamortized debt issuance cost.
(g) Reflects the tax effect of adjustments at
an assumed effective tax rate of 26%, which
approximates the blended federal and state
tax rates, and consistently excludes the
impact of other tax credits and incentive
benefits realized.
(h) Excludes adjustments of approximately
$0.9 million and $2.3 million of net earnings
for the three and nine months ended
December 31, 2020, respectively, and
excludes adjustments of approximately
$0.6 million and $1.8 million of net earnings
for the three and nine months ended
December 31, 2019, associated with the
application of the two-class method for
computing diluted earnings per share.
Three Months Ended
December 31,
Nine Months Ended
December 31,
(In thousands, except share and per share data) 	2020 	2019 	2020 	2019
(Unaudited) 	(Unaudited)
Revenue, Excluding Billable Expenses
Revenue 	$ 	1,904,020 	$ 	1,849,441 	$ 	5,879,658 	$ 	5,494,194
Billable expenses 	577,059 	600,522 	1,729,788 	1,691,543
Revenue, Excluding Billable Expenses 	$ 	1,326,961 	$ 	1,248,919 	$ 	4,149,870 	$ 	3,802,651
Adjusted Operating Income
Operating Income 	$ 	184,257 	$ 	169,045 	$ 	583,365 	$ 	520,126
Transaction expenses (a) 	— 	1,069 	— 	1,069
COVID-19 supplemental employee benefits (b) 	68 	— 	577 	—
Adjusted Operating Income 	$ 	184,325 	$ 	170,114 	$ 	583,942 	$ 	521,195
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin on Revenue & Adjusted
EBITDA Margin on Revenue, Excluding Billable Expenses
Net income 	$ 	144,371 	$ 	112,026 	$ 	409,781 	$ 	343,737
Income tax expense 	21,612 	34,697 	102,418 	106,993
Interest and other, net (c) 	18,274 	22,322 	71,166 	69,396
Depreciation and amortization 	21,113 	20,655 	62,860 	60,308
EBITDA 	205,370 	189,700 	$ 	646,225 	$ 	580,434
Transaction expenses (a) 	— 	1,069 	— 	1,069
COVID-19 supplemental employee benefits (b) 	68 	— 	577 	—
Adjusted EBITDA 	$ 	205,438 	$ 	190,769 	$ 	646,802 	$ 	581,503
Adjusted EBITDA Margin on Revenue 	10.8 % 	10.3 % 	11.0 % 	10.6 %
Adjusted EBITDA Margin on Revenue, Excluding Billable Expenses 	15.5 % 	15.3 % 	15.6 % 	15.3 %
Adjusted Net Income
Net income 	$ 	144,371 	$ 	112,026 	$ 	409,781 	$ 	343,737
Transaction expenses (a) 	— 	1,069 	— 	1,069
COVID-19 supplemental employee benefits (b) 	68 	— 	577 	—
Research and development tax credit (d) 	— 	— 	(2,928) 	—
Release of income tax reserves (e) 	— 	— 	(29) 	—
Loss on debt extinguishment (f) 	— 	— 	13,239 	—
Amortization and write-off of debt issuance costs and debt discount 	705 	886 	1,722 	1,945
Adjustments for tax effect (g) 	(201) 	(509) 	(4,040) 	(784)
Adjusted Net Income 	$ 	144,943 	$ 	113,472 	$ 	418,322 	$ 	345,967
Adjusted Diluted Earnings Per Share
Weighted-average number of diluted shares outstanding 	138,886,119 	141,558,427 	138,932,125 	141,348,635
Adjusted Net Income Per Diluted Share (h) 	$ 	1.04 	$ 	0.80 	$ 	3.01 	$ 	2.45
Free Cash Flow
Net cash provided by operating activities 	$ 	232,935 	$ 	99,780 	$ 	798,959 	$ 	366,459
Less: Purchases of property, equipment, and software 	(15,949) 	(30,734) 	(54,033) 	(90,712)
Free Cash Flow 	$ 	216,986 	$ 	69,046 	$ 	744,926 	$ 	275,747

-- 12 of 14 --

13
FINANCIAL RESULTS – KEY DRIVERS
Third Quarter Fiscal 2021 	– Below is a summary of the key factors driving results for the fiscal 2021 third quarter ended December 31, 2020
as compared to the prior year period:
• 	Revenue increased by 3.0% to $1.9 billion and Revenue, Excluding Billable Expenses increased 6.2% to $1.3 billion, with both increases
primarily driven by growth in client demand and headcount to meet that demand. The Company also benefited from higher staff
utilization over the prior year period driven by fewer PTO days taken by our employees which resulted in increases in our direct labor
and corresponding generation of revenue growth. Revenue growth for the quarter was also negatively impacted by lower billable
expenses primarily due to lower subcontractor costs driven by client demand and timing of client needs and lower direct cost purchases
for clients, including travel. The impact of COVID-19, including on travel, drove volatility in the timing and magnitude of billable
expenses.
• 	Operating Income increased 9.0% to $184.3 million and Adjusted Operating Income increased 8.4% to $184.3 million. Increases in both
were primarily driven by the same factors driving revenue growth as well as strong contract level performance, ongoing cost
management efforts, and reductions in certain types of expenses, like travel and meetings. These were partially offset by the inability to
recognize revenue on, or bill for, fee on certain contracts involving a ready workforce of approximately $2.0 million.
• 	Net income increased 28.9% to $144.4 million and Adjusted Net Income increased 27.7% to $144.9 million. These changes were
primarily driven by the same factors as Operating Income and Adjusted Operating Income. Net income and Adjusted Net Income were
also affected by the release of $10.2 million in reserves for uncertain tax positions related to the acquisition of eGov Holdings, Inc.
(d/b/a Aquilent), established in the fourth quarter of fiscal 2017, due to the expiration of the statute of limitations, and a $3.1 million
gain from the sale of certain Company assets.
• 	EBITDA increased 8.3% to $205.4 million and Adjusted EBITDA increased 7.7% to $205.4 million. These increases were due to the same
factors as Operating Income and Adjusted Operating Income.
• 	Diluted EPS increased to $1.03 from $0.79 and Adjusted Diluted EPS increased to $1.04 from $0.80. The changes were primarily driven
by the same factors as Net Income and Adjusted Net Income, respectively, as well as decreased interest expense and a lower share
count in the third quarter of fiscal 2021.
• 	As of December 31, 2020, total backlog was $23.3 billion, an increase of 6.1%. Funded backlog was $3.6 billion, an increase of 2.8%.

-- 13 of 14 --

14
FINANCIAL RESULTS – KEY DRIVERS
Nine Months Ended December 31, 2020 	– Below is a summary of the key factors driving results for the fiscal 2021 nine months ended
December 31, 2020 as compared to the prior year period:
• 	Net cash provided by operating activities was $799.0 million for the nine months ended December 31, 2020 as compared to $366.5
million in the prior year period. The increase in operating cash flows was primarily due to strong cash collections of our revenue growth,
working capital management, and lower cash taxes due to the carryover of research and development credits claimed in fiscal 2020.
Lower cash disbursements also contributed to third quarter performance, driven by cost management and lower expenses attributable
to COVID-19. Free Cash Flow was $744.9 million for the nine months ended December 31, 2020 as compared to $275.7 million in the
prior year period. Free Cash Flow was affected by the same factors affecting cash provided by operating activities, as well as a decrease
in capital expenditures reflecting a shift away from facilities investment towards technology and tools needed to support the virtual
work environment. Additionally, we continue to modernize our corporate information technology infrastructure and are in the rigorous
testing phase prior to the implementation of a new financial management system. We believe we are on track for a successful
implementation in the next fiscal year, which will support the Company's growth into the future.

-- 14 of 14 --